RxDoctor Payments Data

Jennifer Olson, MD

Family Medicine · China Grove, NCNPI 1659378909

Payments from drug & device makers

$1,894in general payments, 2019–2025

Across 108 payments — averaging $17.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$463
  • Novo Nordisk$450
  • Pfizer$340
  • GSK$187
  • AstraZeneca$119
  • E.r. Squibb & Sons, L.L.C.$69
  • plus $267 from 9 others

What the payments were for

  • Food & beverage$1,894100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,894 in reported general payments places this provider in the 75th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$25,493
Medicare patients
76
Services billed
367

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide47$49,726
JardianceEmpagliflozin27$25,547
FarxigaDapagliflozin Propanediol15$19,278
TrulicityDulaglutide19$19,139
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$18,398
EliquisApixaban15$14,297
Tresiba Flextouch U-200Insulin Degludec12$12,967
MounjaroTirzepatide12$12,123
MyrbetriqMirabegron14$8,099
XareltoRivaroxaban12$8,075
Lantus SolostarInsulin Glargine,hum.Rec.Anlog33$5,459
Levemir FlexpenInsulin Detemir15$2,503
Gabapentin109$1,817
Omeprazole121$1,798
Duloxetine Hcl84$1,741

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$450$49,72647 claims
Lilly USA, LLCTrulicity, Mounjaro$40$31,26231 claims
AstraZenecaFarxiga$119$19,27815 claims
GSKTrelegy Ellipta$187$18,39828 claims
PfizerEliquis$340$14,29715 claims
AbbVieSynthroid$463$77418 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in China Grove

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →